Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali-Akbar Samadani

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Life Sciences|June 21, 2019
CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cellsSina Rahimi, Amaneh Mohammadi Roushandeh, Ammar Ebrahimi, et al.
Journal of Cell Communication and Signaling|January 26, 2017
Application of unique sequence index (USI) barcode to gene expression profiling in gastric adenocarcinomaSadegh Fattahi, Maryam Pilehchian Langroudi, Ali Akbar Samadani, et al.
Journal of the Egyptian National Cancer Institute|December 4, 2022
MUTYH and KLF6 gene expression fluctuations in tumor tissue and tumor margins tissues of colorectal cancerHoora Naebi, Ahmadreza Bandegi, Fereshteh Talebinasab, et al.
Journal of Cell Communication and Signaling|September 23, 2022
Survival-based bioinformatics analysis to identify hub long non-coding RNAs along with lncRNA-miRNA-mRNA network for potential diagnosis/prognosis of thyroid cancerPejman Morovat, Saman Morovat, Milad Hosseinpour, et al.
Journal of the Egyptian National Cancer Institute|October 28, 2024
Practical immunomodulatory landscape of glioblastoma multiforme (GBM) therapySeyedeh Elham Norollahi, Bahman Yousefi, Fatemeh Nejatifar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 17, 2024
The effects of the combination therapy of chemotherapy drugs on the fluctuations of genes involved in the TLR signaling pathway in glioblastoma multiforme therapySeyedeh Elham Norollahi, Shahrokh Yousefzadeh-Chabok, Bahman Yousefi, et al.
Toxicology Reports|May 27, 2024
A critical review of the recent concept of regulatory performance of DNA Methylations, and DNA methyltransferase enzymes alongside the induction of immune microenvironment elements in recurrent pregnancy lossKosar Babaei, Mohsen Aziminezhad, Ebrahim Mirzajani, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 6, 2018
Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?Ali Akbar Samadani, Seyedeh Elham Noroollahi, Fariborz Mansour-Ghanaei, et al.
Cancer Cell International|October 5, 2024
Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapyArefeh Zabeti Touchaei, Seyedeh Elham Norollahi, Ali Najafizadeh, et al.
Medical Oncology (Northwood, London, England)|July 15, 2023
Immune checkpoint inhibitors promising role in cancer therapy: clinical evidence and immune-related adverse eventsSeyed Mohammadmahdi Meybodi, Bahareh Farasati Far, Ali Pourmolaei, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Life Sciences|June 21, 2019
CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cellsSina Rahimi, Amaneh Mohammadi Roushandeh, Ammar Ebrahimi, et al.
Journal of Cell Communication and Signaling|January 26, 2017
Application of unique sequence index (USI) barcode to gene expression profiling in gastric adenocarcinomaSadegh Fattahi, Maryam Pilehchian Langroudi, Ali Akbar Samadani, et al.
Journal of the Egyptian National Cancer Institute|December 4, 2022
MUTYH and KLF6 gene expression fluctuations in tumor tissue and tumor margins tissues of colorectal cancerHoora Naebi, Ahmadreza Bandegi, Fereshteh Talebinasab, et al.
Journal of Cell Communication and Signaling|September 23, 2022
Survival-based bioinformatics analysis to identify hub long non-coding RNAs along with lncRNA-miRNA-mRNA network for potential diagnosis/prognosis of thyroid cancerPejman Morovat, Saman Morovat, Milad Hosseinpour, et al.
Journal of the Egyptian National Cancer Institute|October 28, 2024
Practical immunomodulatory landscape of glioblastoma multiforme (GBM) therapySeyedeh Elham Norollahi, Bahman Yousefi, Fatemeh Nejatifar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 17, 2024
The effects of the combination therapy of chemotherapy drugs on the fluctuations of genes involved in the TLR signaling pathway in glioblastoma multiforme therapySeyedeh Elham Norollahi, Shahrokh Yousefzadeh-Chabok, Bahman Yousefi, et al.
Toxicology Reports|May 27, 2024
A critical review of the recent concept of regulatory performance of DNA Methylations, and DNA methyltransferase enzymes alongside the induction of immune microenvironment elements in recurrent pregnancy lossKosar Babaei, Mohsen Aziminezhad, Ebrahim Mirzajani, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 6, 2018
Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?Ali Akbar Samadani, Seyedeh Elham Noroollahi, Fariborz Mansour-Ghanaei, et al.
Cancer Cell International|October 5, 2024
Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapyArefeh Zabeti Touchaei, Seyedeh Elham Norollahi, Ali Najafizadeh, et al.
Medical Oncology (Northwood, London, England)|July 15, 2023
Immune checkpoint inhibitors promising role in cancer therapy: clinical evidence and immune-related adverse eventsSeyed Mohammadmahdi Meybodi, Bahareh Farasati Far, Ali Pourmolaei, et al.
Pageof 7